ASN
EGRX

Advisory Services Network’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Advisory Services Network’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8
Closed -$374 – 3795
2020
Q3 		$0 Buy
+8
New +$350 ﹤0.01% 3671
2019
Q4 		– Sell
-100
Closed -$6K – 3284
2019
Q3 		$6K Hold
100
– – ﹤0.01% 2373
2019
Q2 		$6K Hold
100
– – ﹤0.01% 2371
2019
Q1 		$5K Hold
100
– – ﹤0.01% 2130
2018
Q4 		$4K Sell
100
-50
-33% -$2.58K ﹤0.01% 2160
2018
Q3 		$10K Sell
150
-100
-40% -$7.58K ﹤0.01% 1822
2018
Q2 		$20K Sell
250
-1,100
-81% -$69.2K ﹤0.01% 1552
2018
Q1 		$71K Sell
1,350
-800
-37% -$46.5K 0.01% 1178
2017
Q4 		$115K Sell
2,150
-11,825
-85% -$658K 0.01% 944
2017
Q3 		$833K Buy
13,975
+1,750
+14% +$106K 0.1% 271
2017
Q2 		$964K Buy
12,225
+4,225
+53% +$346K 0.13% 228
2017
Q1 		$664K Buy
+8,000
New +$595K 0.1% 280

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Advisory Services Network's EGRX Position: Q4 2020 in Review

Advisory Services Network sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2020, closing a stake of 8 shares — an estimated $374 sold.

Advisory Services Network first reported a position in EGRX in Q1 2017 and held it in 12 quarters. The position peaked at $964K in Q2 2017. 166 funds tracked by Wall St. Rank hold EGRX as of Q4 2020.

  • Advisory Services Network reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Advisory Services Network sold 8 Eagle Pharmaceuticals, Inc. shares in Q4 2020, an estimated $374.
  • Advisory Services Network first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2017 and held it in 12 quarters.
  • Advisory Services Network's Eagle Pharmaceuticals, Inc. position peaked at $964K in Q2 2017.
  • 166 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.